GLOBAL PERSONALIZED CANCER MEDICINE MARKET 2019 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Jul 2019 116
Table of Contents

1 Personalized Cancer Medicine Market Overview
1.1 Product Overview and Scope of Personalized Cancer Medicine
1.2 Classification of Personalized Cancer Medicine by Types
1.2.1 Global Personalized Cancer Medicine Revenue Comparison by Types (2019-2024)
1.2.2 Global Personalized Cancer Medicine Revenue Market Share by Types in 2018
1.2.3 Monoclonal Antibodies
1.2.4 Personalized Cancer Vaccines
1.2.5 Other
1.3 Global Personalized Cancer Medicine Market by Application
1.3.1 Global Personalized Cancer Medicine Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Chronic Myeloid Leukaemia
1.3.5 Bowel Cancer
1.3.6 Other Cancer
1.4 Global Personalized Cancer Medicine Market by Regions
1.4.1 Global Personalized Cancer Medicine Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Personalized Cancer Medicine Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Personalized Cancer Medicine Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Personalized Cancer Medicine Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Personalized Cancer Medicine Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Personalized Cancer Medicine Status and Prospect (2014-2024)
1.5 Global Market Size of Personalized Cancer Medicine (2014-2024)
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Business Overview
2.1.2 Personalized Cancer Medicine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
2.2 Merck
2.2.1 Business Overview
2.2.2 Personalized Cancer Medicine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Personalized Cancer Medicine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
2.4 Amgen
2.4.1 Business Overview
2.4.2 Personalized Cancer Medicine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Amgen Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
2.5 Celgene
2.5.1 Business Overview
2.5.2 Personalized Cancer Medicine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Celgene Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
2.6 Bayer
2.6.1 Business Overview
2.6.2 Personalized Cancer Medicine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bayer Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
2.7 Roche
2.7.1 Business Overview
2.7.2 Personalized Cancer Medicine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Roche Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
2.8 Astellas
2.8.1 Business Overview
2.8.2 Personalized Cancer Medicine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Astellas Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
2.9 Astrazeneca
2.9.1 Business Overview
2.9.2 Personalized Cancer Medicine Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Astrazeneca Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
2.10 Johnson & Johnson
2.10.1 Business Overview
2.10.2 Personalized Cancer Medicine Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Johnson & Johnson Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
2.11 Agilent
2.11.1 Business Overview
2.11.2 Personalized Cancer Medicine Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Agilent Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
2.12 Takeda
2.12.1 Business Overview
2.12.2 Personalized Cancer Medicine Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Takeda Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
3 Global Personalized Cancer Medicine Market Competition, by Players
3.1 Global Personalized Cancer Medicine Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Personalized Cancer Medicine Players Market Share
3.2.2 Top 10 Personalized Cancer Medicine Players Market Share
3.3 Market Competition Trend
4 Global Personalized Cancer Medicine Market Size by Regions
4.1 Global Personalized Cancer Medicine Revenue and Market Share by Regions
4.2 North America Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
4.3 Europe Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
4.5 South America Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
5 North America Personalized Cancer Medicine Revenue by Countries
5.1 North America Personalized Cancer Medicine Revenue by Countries (2014-2019)
5.2 USA Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
5.3 Canada Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
5.4 Mexico Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
6 Europe Personalized Cancer Medicine Revenue by Countries
6.1 Europe Personalized Cancer Medicine Revenue by Countries (2014-2019)
6.2 Germany Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
6.3 UK Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
6.4 France Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
6.5 Russia Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
6.6 Italy Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Personalized Cancer Medicine Revenue by Countries
7.1 Asia-Pacific Personalized Cancer Medicine Revenue by Countries (2014-2019)
7.2 China Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
7.3 Japan Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
7.4 Korea Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
7.5 India Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
8 South America Personalized Cancer Medicine Revenue by Countries
8.1 South America Personalized Cancer Medicine Revenue by Countries (2014-2019)
8.2 Brazil Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
8.3 Argentina Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
8.4 Colombia Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Personalized Cancer Medicine by Countries
9.1 Middle East and Africa Personalized Cancer Medicine Revenue by Countries (2014-2019)
9.2 Saudi Arabia Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
9.3 UAE Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
9.4 Egypt Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
9.5 Nigeria Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
9.6 South Africa Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
10 Global Personalized Cancer Medicine Market Segment by Type
10.1 Global Personalized Cancer Medicine Revenue and Market Share by Type (2014-2019)
10.2 Global Personalized Cancer Medicine Market Forecast by Type (2019-2024)
10.3 Monoclonal Antibodies Revenue Growth Rate (2014-2024)
10.4 Personalized Cancer Vaccines Revenue Growth Rate (2014-2024)
10.5 Other Revenue Growth Rate (2014-2024)
11 Global Personalized Cancer Medicine Market Segment by Application
11.1 Global Personalized Cancer Medicine Revenue Market Share by Application (2014-2019)
11.2 Personalized Cancer Medicine Market Forecast by Application (2019-2024)
11.3 Breast Cancer Revenue Growth (2014-2019)
11.4 Lung Cancer Revenue Growth (2014-2019)
11.5 Chronic Myeloid Leukaemia Revenue Growth (2014-2019)
11.6 Bowel Cancer Revenue Growth (2014-2019)
11.7 Other Cancer Revenue Growth (2014-2019)
12 Global Personalized Cancer Medicine Market Size Forecast (2019-2024)
12.1 Global Personalized Cancer Medicine Market Size Forecast (2019-2024)
12.2 Global Personalized Cancer Medicine Market Forecast by Regions (2019-2024)
12.3 North America Personalized Cancer Medicine Revenue Market Forecast (2019-2024)
12.4 Europe Personalized Cancer Medicine Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Personalized Cancer Medicine Revenue Market Forecast (2019-2024)
12.6 South America Personalized Cancer Medicine Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Personalized Cancer Medicine Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Personalized Cancer Medicine Picture
Table Product Specifications of Personalized Cancer Medicine
Table Global Personalized Cancer Medicine and Revenue (Million USD) Market Split by Product Type
Figure Global Personalized Cancer Medicine Revenue Market Share by Types in 2018
Figure Monoclonal Antibodies Picture
Figure Personalized Cancer Vaccines Picture
Figure Other Picture
Table Global Personalized Cancer Medicine Revenue (Million USD) by Application (2014-2024)
Figure Personalized Cancer Medicine Revenue Market Share by Applications in 2018
Figure Breast Cancer Picture
Figure Lung Cancer Picture
Figure Chronic Myeloid Leukaemia Picture
Figure Bowel Cancer Picture
Figure Other Cancer Picture
Table Global Market Personalized Cancer Medicine Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Personalized Cancer Medicine Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Personalized Cancer Medicine Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Personalized Cancer Medicine Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Personalized Cancer Medicine Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Personalized Cancer Medicine Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Personalized Cancer Medicine Revenue (Million USD) and Growth Rate (2014-2024)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Personalized Cancer Medicine Type and Applications
Table Abbott Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Personalized Cancer Medicine Type and Applications
Table Merck Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Personalized Cancer Medicine Type and Applications
Table Novartis Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Personalized Cancer Medicine Type and Applications
Table Amgen Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Personalized Cancer Medicine Type and Applications
Table Celgene Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Personalized Cancer Medicine Type and Applications
Table Bayer Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Personalized Cancer Medicine Type and Applications
Table Roche Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
Table Astellas Basic Information, Manufacturing Base and Competitors
Table Astellas Personalized Cancer Medicine Type and Applications
Table Astellas Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
Table Astrazeneca Basic Information, Manufacturing Base and Competitors
Table Astrazeneca Personalized Cancer Medicine Type and Applications
Table Astrazeneca Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Personalized Cancer Medicine Type and Applications
Table Johnson & Johnson Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
Table Agilent Basic Information, Manufacturing Base and Competitors
Table Agilent Personalized Cancer Medicine Type and Applications
Table Agilent Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Personalized Cancer Medicine Type and Applications
Table Takeda Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2017-2018)
Table Global Personalized Cancer Medicine Revenue (Million USD) by Players (2014-2019)
Table Global Personalized Cancer Medicine Revenue Share by Players (2014-2019)
Figure Global Personalized Cancer Medicine Revenue Share by Players in 2017
Figure Global Personalized Cancer Medicine Revenue Share by Players in 2018
Figure Global Top 5 Players Personalized Cancer Medicine Revenue Market Share in 2018
Figure Global Top 10 Players Personalized Cancer Medicine Revenue Market Share in 2018
Figure Global Personalized Cancer Medicine Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Personalized Cancer Medicine Revenue (Million USD) by Regions (2014-2019)
Table Global Personalized Cancer Medicine Revenue Market Share by Regions (2014-2019)
Figure Global Personalized Cancer Medicine Revenue Market Share by Regions (2014-2019)
Figure Global Personalized Cancer Medicine Revenue Market Share by Regions in 2018
Figure North America Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Europe Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure South America Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Table North America Personalized Cancer Medicine Revenue by Countries (2014-2019)
Table North America Personalized Cancer Medicine Revenue Market Share by Countries (2014-2019)
Figure North America Personalized Cancer Medicine Revenue Market Share by Countries (2014-2019)
Figure North America Personalized Cancer Medicine Revenue Market Share by Countries in 2018
Figure USA Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Canada Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Mexico Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Table Europe Personalized Cancer Medicine Revenue (Million USD) by Countries (2014-2019)
Figure Europe Personalized Cancer Medicine Revenue Market Share by Countries (2014-2019)
Figure Europe Personalized Cancer Medicine Revenue Market Share by Countries in 2018
Figure Germany Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure UK Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure France Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Russia Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Italy Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Personalized Cancer Medicine Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Personalized Cancer Medicine Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Personalized Cancer Medicine Revenue Market Share by Countries in 2018
Figure China Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Japan Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Korea Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure India Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Table South America Personalized Cancer Medicine Revenue by Countries (2014-2019)
Table South America Personalized Cancer Medicine Revenue Market Share by Countries (2014-2019)
Figure South America Personalized Cancer Medicine Revenue Market Share by Countries (2014-2019)
Figure South America Personalized Cancer Medicine Revenue Market Share by Countries in 2018
Figure Brazil Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Argentina Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Colombia Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Personalized Cancer Medicine Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Personalized Cancer Medicine Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Personalized Cancer Medicine Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Personalized Cancer Medicine Revenue Market Share by Countries in 2018
Figure Saudi Arabia Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure UAE Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Egypt Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure Nigeria Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Figure South Africa Personalized Cancer Medicine Revenue and Growth Rate (2014-2019)
Table Global Personalized Cancer Medicine Revenue (Million USD) by Type (2014-2019)
Table Global Personalized Cancer Medicine Revenue Share by Type (2014-2019)
Figure Global Personalized Cancer Medicine Revenue Share by Type (2014-2019)
Figure Global Personalized Cancer Medicine Revenue Share by Type in 2019
Table Global Personalized Cancer Medicine Revenue Forecast by Type (2019-2024)
Figure Global Personalized Cancer Medicine Market Share Forecast by Type (2019-2024)
Figure Global Monoclonal Antibodies Revenue Growth Rate (2014-2019)
Figure Global Personalized Cancer Vaccines Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Personalized Cancer Medicine Revenue by Application (2014-2019)
Table Global Personalized Cancer Medicine Revenue Share by Application (2014-2019)
Figure Global Personalized Cancer Medicine Revenue Share by Application (2014-2019)
Figure Global Personalized Cancer Medicine Revenue Share by Application in 2019
Table Global Personalized Cancer Medicine Revenue Forecast by Application (2019-2024)
Figure Global Personalized Cancer Medicine Market Share Forecast by Application (2019-2024)
Figure Global Breast Cancer Revenue Growth Rate (2014-2019)
Figure Global Lung Cancer Revenue Growth Rate (2014-2019)
Figure Global Chronic Myeloid Leukaemia Revenue Growth Rate (2014-2019)
Figure Global Bowel Cancer Revenue Growth Rate (2014-2019)
Figure Global Other Cancer Revenue Growth Rate (2014-2019)
Figure Global Personalized Cancer Medicine Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Personalized Cancer Medicine Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Personalized Cancer Medicine Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Personalized Cancer Medicine Revenue Market Forecast (2019-2024)
Figure Europe Personalized Cancer Medicine Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Personalized Cancer Medicine Revenue Market Forecast (2019-2024)
Figure South America Personalized Cancer Medicine Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Personalized Cancer Medicine Revenue Market Forecast (2019-2024)

Table of Contents

Related reports :

(Mar 20)

Market Overview The global Atelo-Gelatin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a...

(Mar 20)

Market Overview The global Poliglecaprone Suture market size is expected to gain market growth in the forecast period of 2020 to 2025...

(Mar 20)

Market Overview The global Braided Suture market size is expected to gain market growth in the forecast period of 2020 to 2025, with ...

(Mar 20)

Market Overview The global Monofilament Suture market size is expected to gain market growth in the forecast period of 2020 to 2025, ...

(Mar 20)

Market Overview The global Polyester Suture market size is expected to gain market growth in the forecast period of 2020 to 2025, wit...

(Mar 20)

Market Overview The global Polypropelene Sutures market size is expected to gain market growth in the forecast period of 2020 to 2025...

Global Info Research

GLOBAL PERSONALIZED CANCER MEDICINE MARKET 2019 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medical Devices market as per your needs. Get the best of Medical Devices research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy